These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22811302)

  • 1. Apheresis in the treatment of idiopathic dilated cardiomyopathy.
    Winters JL
    J Clin Apher; 2012; 27(6):312-9. PubMed ID: 22811302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ig apheresis for the treatment of severe DCM patients.
    Pokrovsky SN; Ezhov MV; Safarova MS; Saidova MA; Shitov VN; Afanasieva MI; Khaustov AI; Adamova IY; Afanasieva OI; Konovalov GA
    Atheroscler Suppl; 2013 Jan; 14(1):213-8. PubMed ID: 23357167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity and idiopathic dilated cardiomyopathy: where we stand?
    Fu M
    Autoimmunity; 2008 Sep; 41(6):415-8. PubMed ID: 18781466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.
    Jahns R; Boivin V; Lohse MJ
    Int J Cardiol; 2006 Sep; 112(1):7-14. PubMed ID: 16872696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.
    Dandel M; Wallukat G; Englert A; Hetzer R
    Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL; Vinci A; Iliceto S
    Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
    Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
    G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects.
    Felix SB; Staudt A
    Int J Cardiol; 2006 Sep; 112(1):30-3. PubMed ID: 16860418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apheresis of immunoglobulins - new approach to the treatment of severe dilated cardiomyopathy].
    Konovalov GA; Belenkov IuN; Zvezdkin PV; Chebyshev AN; Semin SN; Kuznetsova IuV; Adamova IIu; Kipor SG; Pokrovskiĭ SN
    Kardiologiia; 2002; 42(6):92-6. PubMed ID: 12494138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange treatment to reduce anti-beta1-adrenergic receptor antibody in a patient with dilated cardiomyopathy.
    Gesinde MO; Tan LB; Gooi HC
    J Clin Apher; 2007; 22(4):241-2. PubMed ID: 17385717
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoadsorption in patients with dilated cardiomyopathy.
    Herda LR; Felix SB; Staudt A
    Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation in dilated cardiomyopathy.
    Pankuweit S; Ruppert V; Maisch B
    Herz; 2004 Dec; 29(8):788-93. PubMed ID: 15599676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.
    Jahns R; Boivin V; Hein L; Triebel S; Angermann CE; Ertl G; Lohse MJ
    J Clin Invest; 2004 May; 113(10):1419-29. PubMed ID: 15146239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
    Dandel M; Wallukat G; Potapov E; Hetzer R
    Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy.
    Jahns R; Boivin V; Lohse MJ
    Trends Cardiovasc Med; 2006 Jan; 16(1):20-4. PubMed ID: 16387626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadsorption in dilated cardiomyopathy.
    Dörffel WV; Wallukat G; Baumann G; Felix SB
    Ther Apher; 2000 Jun; 4(3):235-8. PubMed ID: 10910026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip.
    Horn S; Lueking A; Murphy D; Staudt A; Gutjahr C; Schulte K; König A; Landsberger M; Lehrach H; Felix SB; Cahill DJ
    Proteomics; 2006 Jan; 6(2):605-13. PubMed ID: 16419013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.